SCHEMBL7444573

SCHEMBL7444573

N#Cc1ccc(OC(Cl)CCc2ccc(Cl)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.46
MAOB P27338 5/20 0.45
MAOA P21397 2/20 0.45
PPARG P37231 5/20 0.43
PPARA Q07869 5/20 0.43
CYP19A1 P11511 2/20 0.43
MMP12 P39900 1/20 0.40
MMP13 P45452 1/20 0.40
POLB P06746 1/20 0.39
ADRB2 P07550 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KCNJ1 P48048 1/20 0.38
KCNH2 Q12809 1/20 0.38
AKR1B1 P15121 1/20 0.37
CYP2A6 P11509 1/20 0.37
S1PR1 P21453 1/20 0.37
S1PR3 Q99500 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7443466 0.84 ABCB1 (0.52) MAOBMAOAPPARGPPARACYP19A1
SCHEMBL10419456 0.74 PPARA (0.73) PPARGPPARA
SCHEMBL6980988 0.74 MAOB (0.68) MAOBMAOACYP19A1POLBADRB2
SCHEMBL21709997 0.72 ALDH1A1 (0.47) MAOBMAOACYP19A1MMP12MMP13
SCHEMBL6006311 0.72 SLC6A4 (0.46) MAOBMAOACYP19A1POLBADRB2
SCHEMBL2259191 0.70 MAOB (0.57) MAOBMAOACYP19A1POLBHTT
SCHEMBL31739252 0.70 MAOA (0.61) CNR1MAOBMAOACYP19A1POLB
SCHEMBL72752 0.70
SCHEMBL6225201 0.70 TAAR1 (0.44) MAOBPPARGPPARAKCNH2
SCHEMBL11122145 0.70 MAOB (0.56) CNR1MAOBMAOACYP19A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1014966-A4 PHARMACEUTICAL FOR TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS ALLELIX NEUROSCIENCE INC (US) 2001-10-04 EP disclosed
EP-1014966-A1 PHARMACEUTICAL FOR TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS Allelix Neuroscience Inc. (US) 2000-07-05 EP disclosed
WO-1997045115-A1 PHARMACEUTICAL FOR TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS TROPHIX PHARMACEUTICALS, INC. (US) 1997-12-04 WO disclosed